Privately held ArsenalBio pioneers programmable cell therapy to conquer cancer through solid tumor treatment. Committed to diversity, they value diverse backgrounds for enriched creativity and innovation. Their comprehensive approach spans cell isolation, engineering, expansion, and infusion, creating a genetically programmed T-cell to combat solid tumors.
